| Study sample characteristics |
All infusions n=62
(100 %) |
Complicated infusions n =23 (37.1%) |
| Age |
| Birth-28 days |
24 (38.7%) |
5 (21.7%) |
| 1-23 months |
10 (16.1%) |
4 (17.4%) |
| 2–5 years |
11 (17.7%) |
4 (17.4%) |
| 6-9 years |
13 (20.9%) |
10 (43.5%) |
| ≥ 10 years |
4 (6.4%) |
0 (0%) |
| Indications (diagnostic category) |
| Infections |
23 (37.1%) |
6 (26.1%) |
| Hematological disorders |
11 (17.7%) |
3 (13%) |
| Neurological disorders |
11 (17.7%) |
4 (17.4%) |
| Other autoimmune disorders |
6 (9.7%) |
2 (8.7%) |
| Primary immunodeficiency disorders (PIDs) |
5 (8.1%) |
4 (17.4%) |
| PIDs with hematological disorders |
4 (6.4%) |
4 (17.4%) |
| Unclear diagnosis |
2 (3.2%) |
0 (0 %) |
| Risk factors |
| No risk factors |
45 (72.5%) |
9 (39.1%) |
| Nephrotoxic drugs |
11 (17.7%) |
8 (34.8%) |
| Suspected autoimmune disorders |
7 (11.3%) |
7 (30.4%) |
| Preexisting renal problems |
6 (9.7%) |
5 (21.7%) |
| Allergy |
4 (6.4%) |
3 (13%) |
| Type I diabetes mellitus |
2 (3.2%) |
2 (8.7%) |
| Multiple risk factors |
10 (16.1%) |
9 (39.1%) |
| One risk factor |
7 (11.3%) |
5 (21.7%) |
